Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

138. COVID-19: Research: Friday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Research

(1363) Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mAb) in Development for COVID-19 Prevention

Friday, October 13, 2023
12:15 PM – 1:30 PM US ET
Location: Hall B + C